Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F4C98ACF.svg?ark=w1%2F20260515%2FF4C98ACF)](https://nobleid.org/work/w1/20260515/F4C98ACF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors